septic-shock

Documents about septic-shock

• Lidocaine as an Adjuvant for Ketamine in Induction of Anesthesia in Septic Shock Patients#917696ClinicalTrials.gov
• Efferon LPS Hemoperfusion for Treatment of Patients With Septic Shock#979512ClinicalTrials.gov
• Proadrenomedullin and Copeptin in Patients With Septic Shock#980501ClinicalTrials.gov
• Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction#123495ClinicalTrials.gov
• Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock#253036ClinicalTrials.gov
• Hemodynamic and Inflammatory Effects of Abrupt Versus Tapered Corticosteroid Discontinuation in Septic Shock#828644ClinicalTrials.gov
• Thyroid Hormone Supplementation in Patients With Septic Shock#899017ClinicalTrials.gov
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock#982195ClinicalTrials.gov
• Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic Shock#873720ClinicalTrials.gov
• Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock#471589ClinicalTrials.gov
• Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock#841670ClinicalTrials.gov
• ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)#891580ClinicalTrials.gov
• Doppler Echocardiography Versus Clinical Targets Guided Therapy on the Outcome of Postpartum Septic Shock.#899425ClinicalTrials.gov
• Adjunctive Fludrocortisone in Septic Shock#859262ClinicalTrials.gov
• Continuous Infusion Versus Intermittent Bolus Hydrocortisone in Septic Shock#966990ClinicalTrials.gov
• The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock#398228ClinicalTrials.gov
• Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic Shock#802764ClinicalTrials.gov
• Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)#810680ClinicalTrials.gov
• Esmolol Effects on Heart and Inflammation in Septic Shock#833295ClinicalTrials.gov
• Natriuresis as a Predictor of the Haemodynamic Response to Steroid Replacement Therapy in Patients in Septic Shock#839504ClinicalTrials.gov
• The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock#851451ClinicalTrials.gov
• Assessing Baseline Cortisol Levels in Patients Admitted With Septic Shock in Intensive Care Unit#883961ClinicalTrials.gov
• Hemoadsorpion in Patients With Septic Shock: Efficacy and Safety Evaluation#979328ClinicalTrials.gov
• Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock#851023ClinicalTrials.gov
• Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock#902156ClinicalTrials.gov
• Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock#907807ClinicalTrials.gov
• Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock#839981ClinicalTrials.gov
• A Non-invasive Approach to the Assessment of Volume Status in Mechanically Ventilated Septic Patients.#880488ClinicalTrials.gov
• Aminoglycoside Administration in Septic Patients#125882ClinicalTrials.gov
• GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock#811915ClinicalTrials.gov
• Fluid Balance in the ICU - Interventions to Minimize Fluids in Patients With Septic Shock#911168ClinicalTrials.gov
• Septic Shock and Delirium Because of rSO2 Abnormalities in Intensive Care Unit Patients (The SAD BRAIN Study)#966952ClinicalTrials.gov
• Role of Transposable Elements in Septic Immune Aging#850130ClinicalTrials.gov
• Hydrocortisone 50 mg Every 6 Hours Compared to Hydrocortisone 300 mg Per Day in Treatment of Septic Shock.#802661ClinicalTrials.gov
• Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock#829605ClinicalTrials.gov
• Critical Closing Pressure and PCO₂ Gap in Fluid Resuscitation for Septic Shock#835274ClinicalTrials.gov
• Effect of Norepinephrine Administration on Ventricular Systolic Function in Septic Shock#854917ClinicalTrials.gov
• Volemic Resuscitation in Sepsis and Septic Shock#902686ClinicalTrials.gov
• Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication#903907ClinicalTrials.gov
• Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure#910213ClinicalTrials.gov
• Saving Lives by Early Detection and Treatment of Sepsis and Septic Shock by Point of Care Lactate Test in Adults#873589ClinicalTrials.gov
• Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysfunction#807601ClinicalTrials.gov
• Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock#876765ClinicalTrials.gov
• Non-Invasive Cardiac Output Monitor (NICOM) for Goal-directed Fluid Resuscitation for Inpatients With Hypotension and/or Septic Shock#899147ClinicalTrials.gov
• The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic Shock#978957ClinicalTrials.gov
• Early Intravenous Hydrocortisone in Sepsis#884638ClinicalTrials.gov
• The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)#6817OpenAlex
• Evaluating the generalisability of LiSep LSTM for early prediction of septic shock across US and european cohorts#784483Europe PMC
• IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals#841355ClinicalTrials.gov
• Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock#846050ClinicalTrials.gov